Analysts expect Fate Therapeutics Inc to report revenue of 1.13 M for Q3 26, against a range of 1.08 M to 1.18 M. The most recent reported quarter, Q2 26, came in at 2.08 M, a 1.5% beat against the 2.05 M consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 3.07 M | 1.86 M | 1.63 M | 1.91 M | 1.74 M | 1.37 M | 1.30 M | 2.08 M | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 1.26 M | 1.45 M | 1.09 M | 900,325.74 | 1.49 M | 1.39 M | 1.45 M | 2.20 M | 1.18 M | 1.18 M | 1.04 M | 1.00 M | 863,227.16 | 941,040.67 | 1.28 M | 1.43 M | ||||||||||
| Low Estimate | 1.07 M | 1.22 M | 973,571.14 | 777,261.30 | 1.32 M | 1.19 M | 1.34 M | 1.90 M | 1.08 M | 983,562.51 | 945,318.18 | 877,419.47 | 714,055.64 | 777,114.89 | 1.16 M | 1.33 M | ||||||||||
| Consensus Estimate | 1.16 M | 1.34 M | 1.03 M | 838,793.52 | 1.40 M | 1.29 M | 1.40 M | 2.05 M | 1.13 M | 1.08 M | 990,727.17 | 941,058.56 | 788,641.40 | 859,077.78 | 1.22 M | 1.38 M |
Analysts expect Fate Therapeutics Inc to report earnings per share of -0.28 for Q3 26, against a range of -0.29 to -0.27. The most recent reported quarter, Q2 26, came in at -0.25, a 3.8% beat against the -0.26 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.40 | -0.44 | -0.32 | -0.29 | -0.27 | -0.27 | -0.26 | -0.25 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.39 | -0.37 | -0.37 | -0.33 | -0.27 | -0.25 | -0.26 | -0.24 | -0.27 | -0.26 | -0.25 | -0.25 | -0.24 | -0.25 | -0.25 | -0.26 | ||||||||||
| Low Estimate | -0.47 | -0.43 | -0.41 | -0.39 | -0.33 | -0.27 | -0.28 | -0.28 | -0.29 | -0.28 | -0.29 | -0.29 | -0.26 | -0.29 | -0.27 | -0.28 | ||||||||||
| Consensus Estimate | -0.43 | -0.40 | -0.39 | -0.36 | -0.30 | -0.26 | -0.27 | -0.26 | -0.28 | -0.27 | -0.27 | -0.27 | -0.25 | -0.27 | -0.26 | -0.27 |
Pull Wall Street consensus for Fate Therapeutics Inc (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=FATE&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "FATE", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=FATE&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();